Lead party: Witamax (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Data Pathology SARL (private company) · Sector: Healthcare, Digital Health Platforms, Telemedicine Providers · Countries of operation: Democratic Republic of the Congo (DRC), Senegal, Morocco
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Deal amount: US$223,000
Lead investor/buyer: Witamax · Investors/buyers: Witamax
Legal advisers: not identified in the source record.
Source: announced 20 September 2021. Original announcement: techinafrica.com.


